Medtronic (MDT) Tops Q3 EPS by 2c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $104.96 +6.15%
Revenue Growth %: +5.3%
Financial Fact:
Net earnings: 977M
Today's EPS Names:
KTB, CABO, FDUS, More
Revenue Growth %: +5.3%
Financial Fact:
Net earnings: 977M
Today's EPS Names:
KTB, CABO, FDUS, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q3 EPS of $1.36, $0.02 better than the analyst estimate of $1.34. Revenue for the quarter came in at $9 billion versus the consensus estimate of $8.91 billion.
GUIDANCE:
Medtronic sees FY2026 EPS of $5.62-$5.66, versus the consensus of $5.65.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- NewLake Capital Partners, Inc. (NLCP) Misses Q2 EPS by 9c
- Progyny (PGNY) Tops Q3 EPS by 21c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
